Related Experiment Videos
[Cryptorchidism and testicular cancer]
J G Pereira Arias1, A Astobieta Odriozola, I Zabalza Estévez
1Servicio de Urología, Hospital de Galdakao, Vizcaya, España.
Archivos Espanoles De Urologia
|November 1, 1995
Summary
Undescended testes (cryptorchidism) significantly increase testicular cancer risk, with a 3.5 to 5 times higher chance of malignancy. Early detection through orchiopexy is crucial for managing this elevated risk.
Area of Science:
- Urology
- Oncology
- Reproductive Medicine
Background:
- Cryptorchidism, the failure of testes to descend, is a known risk factor for testicular cancer.
- The incidence of testicular germ cell tumors is higher in patients with a history of cryptorchidism.
Observation:
- A patient with a history of cryptorchidism and prior orchiopexy developed a seminoma-like tumor 15 years post-surgery.
- Testicular biopsy revealed atrophy but no dysplasia, highlighting that malignancy can arise without pre-malignant cellular changes.
Findings:
- Cryptorchidism is the primary risk factor for testicular cancer, increasing risk by 3.5 to 5-fold compared to normally descended testes.
- Orchiopexy, while not preventing malignancy, facilitates earlier diagnosis of testicular tumors.
Implications:
- Close surveillance of patients with a history of cryptorchidism is essential for early cancer detection.
- Understanding the pathogenesis of testicular cancer in cryptorchidism is critical for developing preventative strategies.